---
title: Clinical features, diagnosis, treatment, genetic counselling and prevention of common congential disorders
---

{% include metadata %}

# Addendum A: Clinical features, diagnosis, treatment, genetic counselling and prevention of common congenital disorders

{% include figure
   html="<table>
<thead>
  <tr>
    <td colspan="2"><td>Single gene defects</td></td>
  </tr>
  </thead>
  <tbody>
  <tr class="table-subhead">
    <td colspan="2"><td>Common Autosomal Recessive Disorders</td></td>
  </tr>
  <tr>
    <td colspan="2"><td>Oculocutaneous albinism</td>
      <td>(Autosomal recessive – 1 in 5000 in sub Saharan Africa)</td></td>
  </tr>
  <tr>
    <td><td>Clinical features:</td>
      <td>Skin, hair and retina lack of pigmented</td>
      <td>Skin and eye hypersensitivity to sunlight</td>
      <td>Increased risk of skin cancer</td>
      <td>Reduced visual acuity and nystagmus</td>
      <td><br />
      </td>
      <td>Diagnosis:</td>
      <td>Clinical diagnosis</td>
      <td>DNA diagnosis available**</td></td>
    <td><td>Treatment and Counselling:</td>
      <td>Treat skin infections*</td>
      <td>Sunscreen*</td>
      <td>Surgery for skin cancer</td>
      <td>Glasses for reduced vision</td>
      <td>Genetic counselling*</td>
      <td>Advice on skin and eye care and coverage with clothes and wide brimmed hats*</td>
      <td><br />
      </td>
      <td>Prevention:</td>
      <td>1° – Family planning, family history* and preconception DNA carrier screening**</td>
      <td>2° – Prenatal carrier screening and prenatal DNA diagnosis**</td>
      <td>3° – Early detection* and treatment of skin cancer</td></td>
  </tr>
  <tr class="table-subhead">
    <td colspan="2"><td>Common Autosomal Recessive Disorders</td></td>
  </tr>
  <tr>
    <td colspan="2"><td>Cystic fibrosis</td>
      <td>(Autosomal recessive – 1 in 2000 European and 1 in 2500 in Middle Eastern countries)</td></td>
  </tr>
  <tr>
    <td><td>Clinical features:</td>
      <td>Recurrent chest infections and wheeze</td>
      <td>Clubbing of fingers</td>
      <td>Chronic diarrhoea</td>
      <td>Malabsorption</td>
      <td>Failure to thrive</td>
      <td><br />
      </td>
      <td>Diagnosis:</td>
      <td>Sweat test**</td>
      <td>DNA diagnosis**</td></td>
    <td><td>Treatment and Counselling:</td>
      <td>Aggressive treatment of respiratory infections (antibiotics, bronchodilators, physiotherapy)</td>
      <td>Pancreatic enzyme replacement</td>
      <td>Gene therapy in the future</td>
      <td>Genetic counseling**</td>
      <td>Prevention:</td>
      <td>1° – Family planning, family history* and preconception carrier screening**</td>
      <td>2° – Prenatal carrier screening and prenatal diagnosis**</td>
      <td>3° – Newborn screen</td></td>
  </tr>
  <tr>
    <td colspan="2"><td>Sickle cell anaemia</td>
      <td>(Autosomal recessive. Birth prevalence varies in different countries – 1 in 50 newborns in Nigeria)</td></td>
  </tr>
  <tr>
    <td><td>Clinical features:</td>
      <td>Moderate to severe haemolytic anaemia</td>
      <td>Haemolytic or aplastic crises</td>
      <td>Jaundice</td>
      <td>Initially splenomegaly but later this disappears</td>
      <td>Hyposplenism</td>
      <td>Increased susceptibility to infection (especially Streptococcus pneumoniae, Haemophilus influenzae, Salmonella, malaria)</td>
      <td>Vaso-occlusive episodes (abdominal including kidneys and spleen, dactylitis, priapism, stroke)</td>
      <td>Leg ulcers, aseptic necrosis of bone</td>
      <td>Cholelithiasis (gallstones)</td>
      <td><br />
      </td>
      <td>Diagnosis:</td>
      <td>Full Blood Count-normocytic/mildly macrocytic anaemia, reticulocytosis, target cells</td>
      <td>Haemoglobin electrophoresis-increased haemoglobin F and S</td>
      <td>Positive sickling test</td>
      <td>Increased serum bilirubin</td>
      <td>DNA diagnosis**</td>
      <td>X-rays - increased medullary spaces and cortical thinning, avascular necrosis of bone</td></td>
    <td><td>Treatment and Counselling:</td>
      <td>Prevention or early treatment of infections (vaccines, antibiotics, anti-malarials)*</td>
      <td>Maintain hydration to prevent crises</td>
      <td>Manage crises and acute complications</td>
      <td>Genetic counselling*</td>
      <td><br />
      </td>
      <td>Prevention:</td>
      <td>1° – Family planning, family history* and preconception population carrier screening**</td>
      <td>2° – Prenatal carrier screening and prenatal diagnosis**</td>
      <td>3° – Newborn screening</td></td>
  </tr>
  <tr class="table-subhead">
    <td colspan="2"><td>Rarer Single Gene Defects</td></td>
  </tr>
  <tr>
    <td colspan="2"><td>Neurofibromatosis I</td>
      <td>(Autosomal dominant – 1 in 3000)</td></td>
  </tr>
  <tr>
    <td><td>Clinical features:</td>
      <td>Café-au-lait patches</td>
      <td>Neurofibroma</td>
      <td>Axillary freckling</td>
      <td>Macrocephaly (head circumference above 97th centile)</td>
      <td>Scoliosis</td>
      <td>Learning difficulties</td>
      <td>Complication from compression by neurofibroma</td>
      <td>Increased risk of malignancy in neurofibroma</td>
      <td><br />
      </td>
      <td>Diagnosis:</td>
      <td>Clinical diagnosis</td>
      <td>DNA diagnosis available</td>
      <td>Neurodevelopmental/psychometric assessment</td></td>
    <td><td>Treatment and Counselling:</td>
      <td>Surgery when indicated and if available</td>
      <td>Neurodevelopmental therapy/ community based rehabilitation including psychosocial support</td>
      <td>Genetic counselling**</td>
      <td><br />
      </td>
      <td>Prevention:</td>
      <td>2° – Prenatal diagnosis (DNA diagnosis)</td>
      <td><br />
      </td></td>
  </tr>
  <tr>
    <td colspan="2"><td>Tuberous sclerosis</td>
      <td>(Autosomal dominant – 1 in 15 000)</td></td>
  </tr>
  <tr>
    <td><td>Clinical features:</td>
      <td>Variable expressivity</td>
      <td>Adenoma sebaceum and café-au-lait patches</td>
      <td>Ash leaf patches and shagreen patches</td>
      <td>CNS (cortical) tubers on CT scan</td>
      <td>Renal angiomyolipoma</td>
      <td>Ungual fibroma</td>
      <td>Intellectual disability and epilepsy</td>
      <td><br />
      </td>
      <td>Diagnosis:</td>
      <td>Clinical diagnosis</td>
      <td>DNA diagnosis available</td>
      <td>Neurodevelopmental/psychometric assessment</td></td>
    <td><td>Treatment and Counselling:</td>
      <td>Surgery if indicated</td>
      <td>Neurodevelopmental therapy/ community based rehabilitation including psychosocial support</td>
      <td>Seizure control</td>
      <td>Genetic counselling**</td>
      <td><br />
      </td>
      <td>Prevention:</td>
      <td>2° – Prenatal diagnosis (DNA diagnosis)</td>
      <td><br />
      </td></td>
  </tr>
  <tr>
    <td colspan="2"><td>Huntington disease</td>
      <td>(Autosomal dominant – 1 in 10 000)</td></td>
  </tr>
  <tr>
    <td><td>Clinical features:</td>
      <td>Adult onset (Average age 35 years)</td>
      <td>Progressive involuntary movements (chorea)</td>
      <td>Progressive dementia and psychiatric symptoms</td>
      <td>Weight loss</td>
      <td><br />
      </td>
      <td>Diagnosis:</td>
      <td>DNA diagnosis*** Presymptomatic testing possible**</td>
      <td>Brain scan**</td></td>
    <td><td>Treatment and Counselling:</td>
      <td>No effective treatment. Diagnosis to death averages 15 years</td>
      <td>Psychosocial support</td>
      <td>Genetic counselling</td>
      <td><br />
      </td>
      <td>Prevention:</td>
      <td>1° – Family history*, presymptomatic and pre-pregnancy (DNA) diagnosis** and family planning*</td>
      <td>2° – Prenatal diagnosis (DNA diagnosis)**</td></td>
  </tr>
  <tr>
    <td colspan="2"><td>Achondroplasia</td>
      <td>(Autosomal dominant 1 in 26 000)</td></td>
  </tr>
  <tr>
    <td><td>Clinical features:</td>
      <td>Skeletal dysplasia with asymmetric short stature (short limbs)</td>
      <td>Macrocephaly (head circumference above 97th centile)</td>
      <td>Trident hand. May develop hydrocephalus and spinal cord compression</td>
      <td><br />
      </td>
      <td>Diagnosis:</td>
      <td>Clinical diagnosis</td>
      <td>DNA diagnosis available</td></td>
    <td><td>Treatment and Counselling</td>
      <td>Surgery when indicated and if available</td>
      <td>Avoid contact sports</td>
      <td>Genetic counseling</td>
      <td><br />
      </td>
      <td>Prevention:</td>
      <td>Genetic counselling**</td>
      <td>2° – Prenatal diagnosis (ultrasound** /DNA diagnosis)</td>
      <td><br />
      </td></td>
  </tr>
  <tr>
    <td colspan="2"><td>Myotonic dystrophy</td>
      <td>(Autosomal dominant 1 in 9000)</td></td>
  </tr>
  <tr>
    <td><td>Clinical features:</td>
      <td>Presents usually in young adults. Progressive muscular weakness</td>
      <td>Myotonia and frontal baldness</td>
      <td>Cataracts</td>
      <td>Cardiac conduction defects</td>
      <td>Hypogonadism</td>
      <td>Congenital form (gene inherited from mother) severe hypotonia, facial diplegia, ptosis, arthrogryposis,cataracts</td>
      <td><br />
      </td>
      <td>Diagnosis:</td>
      <td>Electromyography (EMG)**</td>
      <td>DNA diagnosis**</td></td>
    <td><td>Treatment and Counselling:</td>
      <td>Supportive</td>
      <td>Genetic counselling**</td>
      <td><br />
      </td>
      <td>Prevention:</td>
      <td>1° – Family history* and DNA diagnosis**</td>
      <td>Family planning*</td>
      <td>2° – Prenatal diagnosis (DNA diagnosis)**</td>
      <td><br />
      </td></td>
  </tr>
  <tr>
    <td colspan="2"><td>Waardenburg syndrome</td>
      <td>(Autosomal dominant – 1 in 30 000)</td></td>
  </tr>
  <tr>
    <td><td>Clinical features:</td>
      <td>Sensorineural deafness</td>
      <td>Poliosis (White forelock/early greying)</td>
      <td>Sapphire blue eyes or eyes of different colours (heterochromia)</td>
      <td>Partial albinism</td>
      <td>Telecanthus and medial eyebrow flare</td>
      <td><br />
      </td>
      <td>Diagnosis:</td>
      <td>Clinical diagnosis</td>
      <td>Audiology**</td>
      <td>DNA diagnosis**</td></td>
    <td><td>Treatment and Counselling:</td>
      <td>Hearing aid</td>
      <td>Neurodevelopmental therapy/ community based rehabilitation including psychosocial support</td>
      <td>Genetic counselling**</td>
      <td><br />
      </td>
      <td>Prevention:</td>
      <td>Nil</td>
      <td><br />
      </td></td>
  </tr>
  <tr>
    <td colspan="2"><td>Congenital hypothyroidism</td>
      <td>(Autosomal recessive 1 in 4000)</td></td>
  </tr>
  <tr>
    <td><td>Clinical features:</td>
      <td>Feeding problems</td>
      <td>Decreased activity</td>
      <td>Constipation</td>
      <td>Macroglossia (Large tongue)</td>
      <td>Hypothermia and dry skin</td>
      <td>Umbilical hernia</td>
      <td>Intellectual disability/deafness</td>
      <td><br />
      </td>
      <td>Diagnosis:</td>
      <td>Thyroid function tests – Thyroid stimulating hormone (TSH)</td>
      <td>Free thyroxine (T3 and T4)**</td>
      <td>Neurodevelopmental/psychometric assessment**</td>
      <td>Audiological testing (Pendred syndrome – have deafness)**</td></td>
    <td><td>Treatment and Counselling:</td>
      <td>Growth monitoring*</td>
      <td>Thyroxine</td>
      <td>Neurodevelopmental therapy/ community based rehabilitation including psychosocial support</td>
      <td>Genetic counselling**</td>
      <td><br />
      </td>
      <td>Prevention:</td>
      <td>3° – Newborn screening (Not presently done universally in South Africa)</td></td>
  </tr>
  <tr>
    <td colspan="2"><td>Fragile X syndrome</td>
      <td>(X-linked recessive 1 in 2000 males)</td></td>
  </tr>
  <tr>
    <td><td>Clinical features:</td>
      <td>Intellectual disability</td>
      <td>Speech disability</td>
      <td>Autistic-like behaviour</td>
      <td>Macrocephaly</td>
      <td>Long narrow faces with large ears</td>
      <td>Testicular enlargement</td>
      <td><br />
      </td>
      <td>Diagnosis:</td>
      <td>DNA diagnosis**</td>
      <td>Neurodevelopmental/psychometric assessment**</td>
      <td>Neurodevelopmental therapy/ community based rehabilitation including psychosocial support.</td></td>
    <td><td>Treatment and Counselling:</td>
      <td>Genetic counselling**</td>
      <td><br />
      </td>
      <td>Prevention:</td>
      <td>1° – Family history* and carrier screening**</td>
      <td>Family planning*</td>
      <td>2° – Prenatal diagnosis (DNA diagnosis)**</td>
      <td><br />
      </td></td>
  </tr>
  <tr>
    <td colspan="2"><td>Haemophilia A and B</td>
      <td>(X-linked recessive – Haemophilia A 1 in 2000 males/Haemophilia B 1 in 20 000 males)</td></td>
  </tr>
  <tr>
    <td><td>Clinical features:</td>
      <td>Spontaneous bleeding disorder</td>
      <td>Variable clinical expression</td>
      <td>Haemarthrosis</td>
      <td><br />
      </td>
      <td>Diagnosis:</td>
      <td>Prolonged partial thromboplastin time</td>
      <td>Decreased factor VIII (A) or IX (B) in blood**</td>
      <td>DNA diagnosis available**</td></td>
    <td><td>Treatment and Counselling:</td>
      <td>Replace factor VIII (A) or IX (B)*</td>
      <td>Pain relief*</td>
      <td>Splinting*</td>
      <td>Physiotherapy/CBR*</td>
      <td>Genetic counselling*</td>
      <td><br />
      </td>
      <td>Prevention:</td>
      <td>1° – Family history* and DNA carrier screening**</td>
      <td>Family planning*</td>
      <td>2° – Prenatal diagnosis (DNA diagnosis)**</td>
      <td>3° – Avoid injury</td></td>
  </tr>
  <tr>
    <td colspan="2"><td>Duchenne Muscular Dystrophy</td>
      <td>(X-linked recessive 1 in 3700 males)</td></td>
  </tr>
  <tr>
    <td><td>Clinical features:</td>
      <td>Clinical onset 3–5 years of age</td>
      <td>Gait abnormalities</td>
      <td>Weakness of the pelvic girdle</td>
      <td>Gower sign</td>
      <td>Pseudohypertrophy of the calves</td>
      <td>Tightening of the Achilles tendons</td>
      <td>Lumbar lordosis</td>
      <td>Progressive muscle weakness and atrophy of muscles</td>
      <td>Loss of ability to walk by 9-16 years</td>
      <td>Cardiomyopathy/heart failure</td>
      <td>Respiratory failure</td>
      <td>Death by 25 years</td>
      <td><br />
      </td>
      <td>Diagnosis:</td>
      <td>High creatine phosphokinase (CPK)</td>
      <td>DNA diagnosis**</td></td>
    <td><td>Treatment and Counselling:</td>
      <td>Physiotherapy</td>
      <td>Surgery if indicated**</td>
      <td>Cardiac failure treatment*</td>
      <td>Treatment of respiratory infection*</td>
      <td>Wheel chair</td>
      <td>Genetic counselling**</td>
      <td><br />
      </td>
      <td>Prevention:</td>
      <td>1° – Family history* and DNA carrier screening**</td>
      <td>Family planning* and 2° – prenatal diagnosis (DNA diagnosis)**</td></td>
  </tr>
  </tbody>
</table>"
   class="wide"
%}

{% include figure
   html="<table>
<thead>
  <tr>
    <td colspan="2"><td>Chromosomal disorders</td></td>
  </tr>
  </thead>
  <tbody>
  <tr>
    <td colspan="2"><td>Down syndrome</td>
      <td>Currently 1 in 500 live births in South Africa</td></td>
  </tr>
  <tr>
    <td><td>Clinical features:</td>
      <td>Hypotonia</td>
      <td>Intellectual disability</td>
      <td>Craniofacial: brachycephaly, flat face, up-slanting palpebral fissures, epicanthic folds, flat nasal bridge, small, low set ears, squint, relative macroglossia, Brushfield spots (Caucasians)</td>
      <td>Short stature</td>
      <td>Brachydactyly, single palmar creases, 5th finger clinodactyly and hypoplasia mid-phalanx</td>
      <td>Sandal gap between first and second toes, plantar creases</td>
      <td>Small penis/hypogonadism</td>
      <td>Congenital heart disease</td>
      <td>Duodenal atresia</td>
      <td>Recurrent infection, especially of the respiratory tract</td>
      <td><br />
      </td>
      <td>Diagnosis:</td>
      <td>Chromosomal/ FISH analysis/QR-PCR**</td>
      <td>Trisomy 21 – 95%</td>
      <td>Mosaicism – 2.5%</td>
      <td>Translocation – 2.5%</td>
      <td>Thyroid function tests</td>
      <td>Neurodevelopmental/psychometric assessment</td>
      <td>Cardiac assessment</td>
      <td>Audiology</td></td>
    <td><td>Treatment and Counselling:</td>
      <td>Growth monitoring</td>
      <td>Surgery when indicated and available</td>
      <td>Treatment for cardiac failure*</td>
      <td>Treatment of infections*</td>
      <td>Thyroxine if indicated</td>
      <td>Neurodevelopmental therapy/ community based rehabilitation including psychosocial support</td>
      <td>Genetic counselling*</td>
      <td><br />
      </td>
      <td>Prevention:</td>
      <td>1° – Family planning and preconception care*</td>
      <td>2° – Prenatal (AMA) screening* Ultrasound and maternal serum screening for Down syndrome</td>
      <td>Prenatal chromosome/QR-PCR diagnosis**</td></td>
  </tr>
  <tr>
    <td colspan="2"><td>Trisomy 18</td>
      <td>(1 in 1500 live births)</td></td>
  </tr>
  <tr>
    <td><td>Clinical features:</td>
      <td>Decreased fetal movement. Prenatal growth deficiency</td>
      <td>Severe developmental delay</td>
      <td>Hypertonia with weak cry, poor sucking</td>
      <td>Craniofacial: bifrontal narrowing, prominent occiput, microcephaly, low set malformed ears, short palpebral fissures, small chin and mouth, cleft lip/palate</td>
      <td>Clenched hands, overriding fingers</td>
      <td>Rocker-bottom feet, clubfeet</td>
      <td>Congenital heart disease</td>
      <td>Genital hypoplasia</td>
      <td>Neonatal or early infant death</td>
      <td>Diagnosis:</td>
      <td>Chromosomal/ FISH analysis/QR-PCR**</td></td>
    <td><td>Treatment and Counselling:</td>
      <td>Supportive/ Palliative care*</td>
      <td>Genetic counselling*</td>
      <td>Supportive</td>
      <td><br />
      </td>
      <td>Prevention:</td>
      <td><br />
      </td>
      <td>1° – Family planning and preconception care*</td>
      <td>2° – Prenatal screening for chromosomal disorders</td>
      <td>Ultrasound scanning for congential disorders.</td>
      <td>Prenatal diagnosis. Chromosomal/ FISH analysis/QR-PCR.**</td>
      <td><br />
      </td></td>
  </tr>
  <tr>
    <td colspan="2"><td>Trisomy 13</td>
      <td>(1 in 4500 live births)</td></td>
  </tr>
  <tr>
    <td><td>Clinical features:</td>
      <td>Prenatal growth deficiency</td>
      <td>CNS malformations</td>
      <td>Hypertonia/hypotonia with severe developmental delay</td>
      <td>Craniofacial: Microcephaly/ sloping forehead, microphthalmia, anophthalmia, abnormal ears, cleft lip/palate, micrognathia</td>
      <td>Polydactyly, camptodactyly, convex hypoplastic finger nails, cryptorchidism</td>
      <td>Congenital heart disease</td>
      <td>Neonatal or early infant death</td>
      <td>Diagnosis:</td>
      <td>Chromosomal/ FISH analysis/QR-PCR.**</td></td>
    <td><td>Treatment and Counselling:</td>
      <td>Supportive/ Palliative care*</td>
      <td>Genetic counselling*</td>
      <td><br />
      </td>
      <td>Prevention:</td>
      <td>1° – Family planning and preconception care*</td>
      <td>2° – Prenatal screening for chromosomal disorders</td>
      <td>Ultrasound scanning for congential disorders</td>
      <td>Prenatal chromosome diagnosis**</td>
      <td><br />
      </td></td>
  </tr>
  <tr>
    <td colspan="2"><td>Turner syndrome</td>
      <td>(1 in 1000 female live births)</td></td>
  </tr>
  <tr>
    <td><td>Clinical features:</td>
      <td>Female phenotype</td>
      <td>Short stature</td>
      <td>Congenital heart disease (aortic stenosis/ coarctation of aorta)</td>
      <td>Renal anomalies</td>
      <td>Ovarian dysgenesis/infertility</td>
      <td>Learning difficulties</td>
      <td><br />
      </td>
      <td>Diagnosis:</td>
      <td>Chromosomal/ FISH analysis/QF-PCR**</td>
      <td>Monosomy XO/ Turner mosaics</td>
      <td>Neurodevelopmental/psychometric assessment</td>
      <td>Cardiac assessment</td></td>
    <td><td>Treatment and Counselling:</td>
      <td>Growth monitoring*</td>
      <td>Surgery when indicated and if available**</td>
      <td>Ovarian hormone replacement therapy**</td>
      <td>Neurodevelopmental therapy/ community based rehabilitation including psychosocial support</td>
      <td>Genetic counselling**</td>
      <td>Prevention:</td>
      <td>1° – Family planning and preconception care*</td>
      <td>2° – Prenatal screening for chromosomal disorders</td>
      <td>Ultrasound scanning for congential disorders</td>
      <td>Prenatal diagnosis. Chromosomal/ FISH analysis/QR-PCR**</td></td>
  </tr>
  </tbody>
</table>"
   class="wide"
%}


{% include figure
   html="<table>
<thead>
  <tr>
    <td colspan="2"><td>Multifactorial disorders</td></td>
  </tr>
  </thead>
  <tbody>
  <tr>
    <td colspan="2"><td>Spina bifida</td></td>
  </tr>
  <tr>
    <td><td>Clinical features:</td>
      <td>Spinal lesion with paraplegia/ incontinence</td>
      <td>Hydrocephalus and developmental delay</td>
      <td><br />
      </td>
      <td>Diagnosis:</td>
      <td>Clinical diagnosis</td>
      <td>Brain ultrasound/ CAT scan</td>
      <td>Urological assessment</td>
      <td>Neurodevelopmental/psychometric assessment</td></td>
    <td><td>Treatment and Counselling:</td>
      <td>Surgery when indicated and if available</td>
      <td>Incontinence care</td>
      <td>Neurodevelopmental therapy/ community based rehabilitation including psychosocial support</td>
      <td>Palliative care*</td>
      <td>Prevention:</td>
      <td>Genetic counselling*</td>
      <td>1° – Optimising women’s diet. Folic acid supplementation*</td>
      <td>2° – Maternal serum alpha feto-protein screening</td>
      <td>Ultrasound scanning for congential disorders</td></td>
  </tr>
  <tr>
    <td colspan="2"><td>Anencephaly</td></td>
  </tr>
  <tr>
    <td><td>Clinical features:</td>
      <td>Incomplete development and closure of the skull and development of the brain.</td>
      <td>Incompatible with life.</td>
      <td><br />
      </td>
      <td>Diagnosis:</td>
      <td>Clinical diagnosis.</td></td>
    <td><td>Treatment and Counselling:</td>
      <td>Palliative care*</td>
      <td>Prevention:</td>
      <td>Genetic counselling.*</td>
      <td>1° – Optimising women’s diet. Folic acid supplementation.*</td>
      <td>2° – Maternal serum alpha feto-protein screening.</td>
      <td>Ultrasound scanning for congential disorders.</td></td>
  </tr>
  <tr>
    <td colspan="2"><td>Encephalocele</td></td>
  </tr>
  <tr>
    <td><td>Clinical features:</td>
      <td>Incomplete closure of the skull with out-pouching containing neural tissue.</td>
      <td>Microcephaly.</td>
      <td>Developmental delay.</td>
      <td>Seizures.</td>
      <td><br />
      </td>
      <td>Diagnosis:</td>
      <td>Clinical diagnosis.</td>
      <td>Brain scan.</td>
      <td>Neurodevelopmental/psychometric assessment.</td></td>
    <td><td>Treatment and Counselling:</td>
      <td>Surgery when indicated and if possible.</td>
      <td>Neurodevelopmental therapy/ community based rehabilitation including psychosocial support.</td>
      <td>Seizure control.</td>
      <td>Genetic counselling*</td>
      <td><br />
      </td>
      <td>Prevention:</td>
      <td>1° – Optimising women’s diet. Folic acid supplementation.*</td>
      <td>2° – Ultrasound scanning for congential disorders.</td></td>
  </tr>
  <tr>
    <td colspan="2"><td>Cleft lip/palate</td></td>
  </tr>
  <tr>
    <td><td>Clinical features:</td>
      <td>Cleft lip and/or palate.</td>
      <td>Feeding problems.</td>
      <td>Speech difficulties.</td>
      <td><br />
      </td>
      <td>Diagnosis:</td>
      <td>Clinical diagnosis.</td>
      <td>Audiology.</td></td>
    <td><td>Treatment and Counselling:</td>
      <td>Surgery.</td>
      <td>Feeding plate in infancy.</td>
      <td>Neurodevelopmental therapy/ community based rehabilitation including psychosocial support.</td>
      <td>Genetic counselling.*</td>
      <td><br />
      </td>
      <td>Prevention:</td>
      <td>Nil.</td></td>
  </tr>
  <tr>
    <td colspan="2"><td>Talipes equinovarus</td>
      <td>(Clubfoot)</td></td>
  </tr>
  <tr>
    <td><td>Clinical features:</td>
      <td>Fixed equinovarus deformation of the foot (feet).</td>
      <td>X-rays.</td>
      <td><br />
      </td>
      <td>Diagnosis:</td>
      <td>Clinical diagnosis.</td></td>
    <td><td>Treatment and Counselling:</td>
      <td>Manipulation and plaster of Paris casts.</td>
      <td>Surgery when indicated.</td>
      <td>Genetic counselling.*</td>
      <td><br />
      </td>
      <td>Prevention:</td>
      <td>Nil.</td></td>
  </tr>
  </tbody>
  </table>"
   class="wide"
%}

{% include figure
   html="<table>
  <thead>
  <tr>
    <td colspan="2"><td>Teratogens</td></td>
  </tr>
  </thead>
  <tbody>
  <tr>
    <td colspan="2"><td>Fetal alcohol syndrome</td>
      <td>(Prevalence varies between communities. Estimated more than 1% of South African infants are born with FAS)</td></td>
  </tr>
  <tr>
    <td><td>Clinical features:</td>
      <td>Pre- and post natal growth deficiency.</td>
      <td>Microcephaly.</td>
      <td>Intellectual disability.</td>
      <td>Behaviour disorder.</td>
      <td>Craniofacial: short palpebral fissures, short upturned nose, smooth philtrum, thin vermillion border.</td>
      <td>Joint anomalies.</td>
      <td>Congenital heart defects.</td>
      <td><br />
      </td>
      <td>Diagnosis:</td>
      <td>Clinical diagnosis.</td></td>
    <td><td>Treatment and Counselling:</td>
      <td>Neurodevelopmental/psychometric assessment.</td>
      <td>Cardiac assessment.</td>
      <td>Growth monitoring.*</td>
      <td>Surgery when indicated and if available.</td>
      <td>Neurodevelopmental therapy/ community based rehabilitation including psychosocial support.</td>
      <td>Neuro-behavioural management.</td>
      <td>Genetic counseling.*</td>
      <td><br />
      </td>
      <td>Prevention:</td>
      <td>1° – Optimising women’s diet.</td>
      <td>Public education on the bad effects of alcohol use and abuse in pregnancy.*</td></td>
  </tr>
  <tr>
    <td colspan="2"><td>Fetal rubella syndrome</td></td>
  </tr>
  <tr>
    <td><td>Clinical features:</td>
      <td>Growth deficiency.</td>
      <td>Microcephaly.</td>
      <td>Intellectual disability.</td>
      <td>Sensori-neural deafness.</td>
      <td>Cataracts, chorioretinitis, microphthalmia, squint.</td>
      <td>Congenital heart disease (PDA, septal defects, peripheral pulmonary stenosis).</td>
      <td>Hepatosplenomegaly.</td>
      <td>Thrombocytopenia, anaemia.</td>
      <td><br />
      </td>
      <td>Diagnosis:</td>
      <td>Clinical diagnosis.</td>
      <td>Serum IgG and IgM for rubella. Identify virus in urine.</td>
      <td>Neurodevelopmental/psychometric assessment.</td>
      <td>Visual assessment.</td>
      <td>Audiology.</td>
      <td>Cardiac assessment.</td>
      <td>Full Blood Count.</td></td>
    <td><td>Treatment and Counselling:</td>
      <td>Growth monitoring.*</td>
      <td>Surgery when indicated and if available.</td>
      <td>Auditory and vision management.</td>
      <td>Neurodevelopmental therapy/ community based rehabilitation including psychosocial support.</td>
      <td>Genetic counselling.*</td>
      <td><br />
      </td>
      <td>Prevention:</td>
      <td>1° – Preventing maternal infection by mass rubella immunisation.</td>
      <td>2° – Prenatal screening for sero-negativity and immunisation prior to subsequent pregnancy.*</td>
      <td>Detection of congenital malformations with ultrasound screening.</td>
      <td>Avoid contact between pregnant women and ill children</td>
      <td><br />
      </td></td>
  </tr>
  </tbody>
</table>
"
   class="wide"
%}

Abbreviations:

\* Possible in primary health care.  
\*\* Available in South Africa  
1° – Primary prevention (Preconception and early postconception period).  
2° – Secondary prevention (Antenatal period).  
3° – Tertiary prevention (Postnatal period).  
CBR. Community-based rehabilitation  
FISH. Fluorescent in situ hybridisation  

(Adapted from Christianson A L and Modell B. *Medical Genetics in Developing Countries*, Ann. Rev. Genomics Hum Genetics. 2004;5: 219–265).
